YCM
AIMT

Yakira Capital Management’s Aimmune Therapeutics AIMT Stock Holding History

Yakira Capital Management’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-46,826
Closed -$1.61M – 333
2020
Q3 		$1.61M Buy
+46,826
New +$997K 0.48% 61

Yakira Capital Management's AIMT Position: Q4 2020 in Review

Yakira Capital Management sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 46,826 shares — an estimated $1.61M sold.

Yakira Capital Management first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $1.61M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Yakira Capital Management reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Yakira Capital Management sold 46,826 Aimmune Therapeutics shares in Q4 2020, an estimated $1.61M.
  • Yakira Capital Management first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
  • Yakira Capital Management's Aimmune Therapeutics position peaked at $1.61M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Yakira Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.